[HTML][HTML] IL-33 biology in cancer: An update and future perspectives

WJ Yeoh, VP Vu, P Krebs - Cytokine, 2022 - Elsevier
Abstract Interleukin-33 (IL-33) is a member of the IL-1 family of cytokines that is constitutively
expressed in the nucleus of epithelial, endothelial and fibroblast-like cells. Upon cell stress …

Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement

AA Mohamed, RA Zaghloul… - … of Biochemical and …, 2022 - Wiley Online Library
The current study investigates the anti‐inflammatory and hepatoprotective effects of
selenium (Se) formulated as nanoparticles (SeNPs) and in combination with quercetin …

Virus-like nanoparticles (VLPs) based technology in the development of breast cancer‎ vaccines‎

A Arab, AR Nikpoor, P Asadi, R Iraei… - Process …, 2022 - Elsevier
Virus-like nanoparticles (VLPs) resemble structures of viruses that are devoid of the viral
genome, which are widely exerted in vaccine designs, especially cancer vaccines. These …

[HTML][HTML] IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells

CP Tran, M Scurr, L O'Connor, JN Buzzelli, GZ Ng… - Oncotarget, 2022 - ncbi.nlm.nih.gov
Abstract Interleukin-33 (IL-33) is an IL-1 family cytokine known to promote T-helper (Th) type
2 immune responses that are often deregulated in gastric cancer (GC). IL-33 is …

[HTML][HTML] Interleukin-33 and soluble ST2 as potential biomarkers of cancer in opium users: a nested case-control study

N Firouzabadi, K Javdani… - Iranian Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Background: Opium abuse is one of the social hazards in the Middle Eastern countries.
Opium consumption attributes to various malignancies. However, the exact molecular …

Interleukins in the development and progression of breast cancer

MA Aziz, S Jafrin, MS Islam, Y Kabir - 2022 - Springer
Breast cancer is one of the most frequently diagnosed cancers globally, with the highest
mortality in women. Despite remarkable advances in treatment approaches, breast cancer …

The risk of genetic polymorphisms in the immune genes on the developed of respiratory allergic diseases

IH Hamzah, NHAAH Al-Saeed… - Research Journal of …, 2022 - indianjournals.com
Allergic diseases are intricate and improvement includes both natural and hereditary
components. besides classic Tcell-originated T helper form-2 cytokine comparable to IL4; …

[PDF][PDF] Detection of HMGB1, RAGE and IL-33 proinflammatory cytokines in serum of breast cancer patients

MH Hantoosh, MM Kadhim - Teikyo Med J, 2022 - teikyomedicaljournal.com
Breast cancer (BC) is the most frequent cancer in women all around the world [1]. It is the
most frequently diagnosed tumor and has the 6th highest malignancy-related mortality rate …

[PDF][PDF] Sera Level and Polymorphism of Interleukin-33 Gene in Iraqi Females Patients with Breast Cancer

AM Salih, HM Al-Abassi, ZJ Abdulkareem - academia.edu
Abstract Interleukin-33 [IL-33] is a specific ligand for the ST2 receptor, and a member of the
IL-1 family. It is a dual-function protein that acts both as an extracellular alarmin cytokine …

Inflammatory Biomarkers for Cancer

A Corthay, G Haraldsen - Biomarkers of the Tumor Microenvironment, 2022 - Springer
Cancer is associated with various degrees of inflammation locally and systemically, due to
an immunological response towards the malignant lesions. Here, we review several …